GB0127669D0 - Polypeptide - Google Patents
PolypeptideInfo
- Publication number
- GB0127669D0 GB0127669D0 GBGB0127669.0A GB0127669A GB0127669D0 GB 0127669 D0 GB0127669 D0 GB 0127669D0 GB 0127669 A GB0127669 A GB 0127669A GB 0127669 D0 GB0127669 D0 GB 0127669D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0224538A GB2378704B (en) | 1998-11-18 | 1999-11-18 | Uses of 5t4 antigen |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9825303.2A GB9825303D0 (en) | 1998-11-18 | 1998-11-18 | Vector |
GBGB9901739.4A GB9901739D0 (en) | 1999-01-27 | 1999-01-27 | Polypeptide |
GBGB9917995.4A GB9917995D0 (en) | 1999-07-30 | 1999-07-30 | Polypeptide |
GB0014986A GB2347932B (en) | 1998-11-18 | 1999-11-18 | Vectors for the delivery of 5T4 antigen |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0127669D0 true GB0127669D0 (en) | 2002-01-09 |
GB2370571A GB2370571A (en) | 2002-07-03 |
GB2370571B GB2370571B (en) | 2003-05-07 |
Family
ID=27447855
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0127675A Withdrawn GB2370573A (en) | 1998-11-18 | 1999-11-18 | Poxviral vectors |
GB0127673A Expired - Fee Related GB2370572B (en) | 1998-11-18 | 1999-11-18 | Use of a professional antigen presenting cell |
GB0127669A Expired - Fee Related GB2370571B (en) | 1998-11-18 | 1999-11-18 | A modified 5t4 antigen |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0127675A Withdrawn GB2370573A (en) | 1998-11-18 | 1999-11-18 | Poxviral vectors |
GB0127673A Expired - Fee Related GB2370572B (en) | 1998-11-18 | 1999-11-18 | Use of a professional antigen presenting cell |
Country Status (1)
Country | Link |
---|---|
GB (3) | GB2370573A (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7628980B2 (en) | 2000-11-23 | 2009-12-08 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
DE60116371T3 (en) | 2000-11-23 | 2016-11-17 | Bavarian Nordic A/S | VARIANT OF THE MODIFIED VACCINIA ANKARA VIRUS |
US7445924B2 (en) | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
AU2002356690B2 (en) | 2001-12-04 | 2008-07-24 | Bavarian Nordic A/S | Flavivirus NS1 subunit vaccine |
GB0203420D0 (en) | 2002-02-13 | 2002-04-03 | Oxford Biomedica Ltd | Peptide |
GB0203419D0 (en) | 2002-02-13 | 2002-04-03 | Oxford Biomedica Ltd | Peptide |
DK1420822T4 (en) | 2002-04-19 | 2017-10-09 | Bavarian Nordic As | Modified vaccinia virus Ankara for vaccination of newborns |
EP1434858B2 (en) | 2002-09-05 | 2018-12-19 | Bavarian Nordic A/S | Method for the amplification of a poxvirus under serum free conditions |
EP1994055B1 (en) | 2006-03-10 | 2014-07-02 | Wyeth LLC | Anti-5t4 antibodies and uses thereof |
WO2008059252A2 (en) * | 2006-11-15 | 2008-05-22 | Oxford Biomedica (Uk) Limited | Methods and composition fro t cell receptors which recognize 5t4 antigen |
JP7277388B2 (en) | 2017-03-15 | 2023-05-18 | オックスフォード バイオメディカ(ユーケー)リミテッド | Method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
WO1989001973A2 (en) * | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
ATE123652T1 (en) * | 1988-03-04 | 1995-06-15 | Cancer Res Campaign Tech | ANTIGENS. |
CA2227065A1 (en) * | 1995-07-21 | 1997-02-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
-
1999
- 1999-11-18 GB GB0127675A patent/GB2370573A/en not_active Withdrawn
- 1999-11-18 GB GB0127673A patent/GB2370572B/en not_active Expired - Fee Related
- 1999-11-18 GB GB0127669A patent/GB2370571B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2370572A (en) | 2002-07-03 |
GB0127675D0 (en) | 2002-01-09 |
GB2370571B (en) | 2003-05-07 |
GB0127673D0 (en) | 2002-01-09 |
GB2370572B (en) | 2003-05-07 |
GB2370573A (en) | 2002-07-03 |
GB2370571A (en) | 2002-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL344341A1 (en) | Peptides | |
DE59912562D1 (en) | Indolyl-3-glyoxylsäure-derivate mit antitumorwirkung | |
EP1142992A4 (en) | Polypeptides | |
HK1039158A1 (en) | Nlk1-interacting proteins | |
GB0127673D0 (en) | Polypeptide | |
GB9825854D0 (en) | Peptide | |
EP1103604A4 (en) | Novel polypeptide | |
GB9815505D0 (en) | Polypeptide derivatives | |
EP1197556A4 (en) | Useful polypeptide | |
PL344979A1 (en) | Angiostatin-binding protein | |
GB9812675D0 (en) | Peptides | |
GB9816337D0 (en) | Proteins | |
GB9828704D0 (en) | Proteins | |
GB9828880D0 (en) | Protein | |
GB9807890D0 (en) | Peptides | |
GB0224538D0 (en) | Polypeptide | |
HK1045173A1 (en) | Polypeptide | |
GB9819387D0 (en) | Polypeptide | |
GB9812607D0 (en) | Protein | |
GB9819038D0 (en) | Protein | |
GB9809566D0 (en) | Protein | |
EP1127066A4 (en) | Modified proteins | |
GB9816335D0 (en) | Proteins | |
GB0315759D0 (en) | Proteins | |
GB9816336D0 (en) | Proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20171118 |